Sanara MedTech Inc. (SMTI)
NASDAQ (CM) NASDAQ (CM) Primary 
Sanara MedTech Inc. (SMTI) Q4 2024 Earnings Call Transcript
Sanara MedTech Inc. (NASDAQ:SMTI ) Q4 2024 Earnings Conference Call March 25, 2025 8:00 AM ET Company Participants Ron Nixon - Executive Chairman and Chief Executive Officer Seth Yon - President, Commercial Sam Muppalla - Tissue Health Plus Tyler Palmer - Chief Corporate Development and Strategy Officer Elizabeth Taylor - Chief Financial Officer Conference Call Participants Ross Osborn - Cantor Fitzgerald Operator Good day, and welcome to the Sanara MedTech Fourth Quarter and Full-Year 2024 Earnings Conference Call. Please not that this conference call is being recorded and a replay will be available on the investor relations page of the company's website shortly.
Sanara MedTech: A Promising Growth Story At An Attractive Valuation
Shares have risen nearly 15% since the company posted preliminary Q4 results, which showed revenue up by 45-48% year over year. While growth was boosted by one-off demand for its BIASURGE product, underlying growth was still strong at 37%. There remains a long runway for growth for its surgical products, with the potential for this to be augmented by other growth drivers, including inorganic opportunities.
All You Need to Know About Sanara MedTech (SMTI) Rating Upgrade to Buy
Sanara MedTech (SMTI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Sanara MedTech Inc. (SMTI) Q3 2024 Earnings Call Transcript
Sanara MedTech Inc. (NASDAQ:SMTI ) Q3 2024 Earnings Conference Call November 13, 2024 9:00 AM ET Company Participants Ronald Nixon - Executive Chairman and CEO Seth Yon - President of Commercial Michael McNeil - Chief Financial Officer Sam Muppalla - Tissue Health Plus Conference Call Participants Ross Osborn - Cantor Fitzgerald Ian Cassel - MicroCapClub Chris Plahm - Tall Pines Capital John Siedhoff - Twin Oaks Equity Operator Good morning, and welcome to the Sanara MedTech Third Quarter 2024 Earnings Conference Call. The company issued its earnings release yesterday and will post today's supplemental deck on the Investor Relations page on the company's website.
Sanara MedTech Inc (SMTI) Trading 3.79% Higher on Oct 2
Shares of Sanara MedTech Inc (SMTI, Financial) surged 3.79% in mid-day trading on Oct 2. The stock reached an intraday high of $30.10, up from its previous close of $29.00.
Sanara Stock Gains From New US Distribution Deal With ChemoMouthPiece
SMTI, along with InfuSystem, inked a U.S. distribution agreement with ChemoMouthpiece. Under the agreement, ChemoMouthpiece's oral cryotherapy device will be distributed in cancer centers.
